Ayesha BM Kharsany

Prof. Ayesha BM Kharsany

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2016 in The Open AIDS Journal
Verified
Journal Article
Open access
AKAyesha BM Kharsany
Ayesha BM Kharsany
QKQuarraisha Abdool Karim
Quarraisha Abdool Karim
Global trends in HIV infection demonstrate an overall increase in HIV prevalence and substantial declines in AIDS related deaths largely attributable to the survival benefits of antiretroviral treatment. Sub-Saharan Africa carries a disproportionate burden of HIV, accounting for more than 70% of the global burden of infection. Success in HIV prevention in sub-Saharan Africa has the potential to impact on the global burden of HIV. Notwithstanding substantial progress in scaling up antiretroviral therapy (ART), sub-Saharan Africa accounted for 74% of the 1.5 million AIDS related deaths in 2013. Of the estimated 6000 new infections that occur globally each day, two out of three are in sub-Saharan Africa with young women continuing to bear a disproportionate burden. Adolescent girls and young women aged 15-24 years have up to eight fold higher rates of HIV infection compared to their male peers. There remains a gap in women initiated HIV prevention technologies especially for women who are unable to negotiate the current HIV prevention options of abstinence, behavior change, condoms and medical male circumcision or early treatment initiation in their relationships. The possibility of an AIDS free generation cannot be realized unless we are able to prevent HIV infection in young women. This review will focus on the epidemiology of HIV infection in sub-Saharan Africa, key drivers of the continued high incidence, mortality rates and priorities for altering current epidemic trajectory in the region. Strategies for optimizing the use of existing and increasingly limited resources are included.

1 January 2017 in The Lancet HIV
Verified
Journal Article
Open access
TOTulio de Oliveira
Tulio de Oliveira
AKAyesha BM Kharsany
Ayesha BM Kharsany
TGTiago Gräf
Tiago Gräf
CCCherie Cawood
Cherie Cawood
DKDavid Khanyile
David Khanyile
SKSalim S Abdool Karim
Salim S Abdool Karim
The incidence of HIV infection in young women in Africa is very high. We did a large-scale community-wide phylogenetic study to examine the underlying HIV transmission dynamics and the source and consequences of high rates of HIV infection in young women in South Africa. We did a cross-sectional household survey of randomly selected individuals aged 15-49 years in two neighbouring subdistricts (one urban and one rural) with a high burden of HIV infection in KwaZulu-Natal, South Africa. Participants completed structured questionnaires that captured general demographic, socioeconomic, psychosocial, and behavioural data. Peripheral blood samples were obtained for HIV antibody testing. Samples with HIV RNA viral load greater than 1000 copies per mL were selected for genotyping. We constructed a phylogenetic tree to identify clusters of linked infections (defined as two or more sequences with bootstrap or posterior support ≥90% and genetic distance ≤4·5%). From June 11, 2014, to June 22, 2015, we enrolled 9812 participants, 3969 of whom tested HIV positive. HIV prevalence (weighted) was 59·8% in 2835 women aged 25-40 years, 40·3% in 1548 men aged 25-40 years, 22·3% in 2224 women younger than 25 years, and 7·6% in 1472 men younger than 25 years. HIV genotyping was done in 1589 individuals with a viral load of more than 1000 copies per mL. In 90 transmission clusters, 123 women were linked to 103 men. Of 60 possible phylogenetically linked pairings with the 43 women younger than 25 years, 18 (30·0%) probable male partners were younger than 25 years, 37 (61·7%) were aged 25-40 years, and five (8·3%) were aged 41-49 years: mean age difference 8·7 years (95% CI 6·8-10·6; p<0·0001). For the 92 possible phylogenetically linked pairings with the 56 women aged 25-40 years, the age difference dropped to 1·1 years (95% CI -0·6 to 2·8; p=0·111). 16 (39·0%) of 41 probable male partners linked to women younger than 25 years were also linked to women aged 25-40 years. Of 79 men (mean age 31·5 years) linked to women younger than 40 years, 62 (78·5%) were unaware of their HIV-positive status, 76 (96·2%) were not on antiretroviral therapy, and 29 (36·7%) had viral loads of more than 50 000 copies per mL. Sexual partnering between young women and older men, who might have acquired HIV from women of similar age, is a key feature of the sexual networks driving transmission. Expansion of treatment and combination prevention strategies that include interventions to address age-disparate sexual partnering is crucial to reducing HIV incidence and enabling Africa to reach the goal of ending AIDS as a public health threat. President's Emergency Program for AIDS Relief, US Centers for Disease Control and Prevention, South African Medical Research Council, and MAC AIDS Fund.

1 August 2018 in The Lancet HIV
Verified
Journal Article
Closed access
AKAyesha BM Kharsany
Ayesha BM Kharsany
CCCherie Cawood
Cherie Cawood
DKDavid Khanyile
David Khanyile
LLLara Lewis
Lara Lewis
AGAnneke Grobler
Anneke Grobler
QKQuarraisha Abdool Karim
Quarraisha Abdool Karim

1 November 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
AKAyesha BM Kharsany
Ayesha BM Kharsany
CCCherie Cawood
Cherie Cawood
LLLara Lewis
Lara Lewis
NYNonhlanhla Yende-Zuma
Nonhlanhla Yende-Zuma
DKDavid Khanyile
David Khanyile
QKQuarraisha Abdool Karim
Quarraisha Abdool Karim
In Africa, ongoing high HIV incidence in young women1-3 is the leading obstacle to achieving the United Nations goal of global epidemic control by the year 2030.4 In South Africa, the world’s worst-affected country, approximately 7.9 million people of all ages were living with HIV in 2017,5 and among adults aged 15 to 49 years, HIV prevalence was 20.6% (26.3% among women and 14.8% among men). KwaZulu-Natal is the worst-affected province, with a prevalence of 27.0% compared with the western Cape, which has a prevalence of 12.6%. Several studies from KwaZulu-Natal have shown persistently high HIV prevalence6-9 and incidence10 in young women, suggesting that the burden of HIV continues unabated.3,8,11

17 June 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
AKAyesha BM Kharsany
Ayesha BM Kharsany
LMLyle R. McKinnon
Lyle R. McKinnon
LLLara Lewis
Lara Lewis
CCCherie Cawood
Cherie Cawood
DKDavid Khanyile
David Khanyile
CTCarlos Toledo
Carlos Toledo
Sexually transmitted infections (STIs) and Human immunodeficiency virus (HIV) share a complex bidirectional relationship, however, population prevalence and the association between the presence of STIs and HIV in a high HIV burden district in KwaZulu-Natal, South Africa is not known. A total of 9812 participants aged 15-49 years were enrolled in a cross-sectional population-based household survey. Participants completed a structured questionnaire and provided first-pass urine (males) or self-collected vulvo-vaginal swabs (females) for the detection of STIs. Prevalence of herpes simplex virus type-2 (HSV-2) was 57.8%, syphilis was 1.6%, Neisseria gonorrhoeae was 2.8%, Chlamydia trachomatis was 7.1%, Trichomonas vaginalis was 9.0%, Mycoplasma genitalium was 5.5% and HIV was 36.3%. HIV positive status was associated with an increased probability of having M. genitalium (aPR = 1.49, 95% CI 1.02-2.19) among males and syphilis (aPR = 2.54, 95% CI 1.32-4.86), N. gonorrhoeae (aPR = 2.39, 95% CI 1.62-3.52), T. vaginalis (aPR = 1.70, 95% CI 1.43-2.01) and M. genitalium (aPR = 1.60, 95% CI 1.15-2.22) among females. HIV viral load ≥400 copies per mL was associated with an increased probability of N. gonorrhoeae (aPR = 1.91, 95% CI 1.36-2.70), C. trachomatis (aPR = 1.52, 95% CI 1.12-2.05) and M. genitalium (aPR = 1.83, 95% CI 1.27-2.63). The high prevalence of STIs and the association between STIs and HIV, and HIV viral load underscores the public health implications of sustained transmission risk of STIs and HIV. These findings highlight the urgent need for expanding STI surveillance and implementing interventions to monitor and reduce the STI burden.

19 November 2019 in Nature Communications
Verified
Journal Article
Open access
LLLenine Liebenberg
Lenine Liebenberg
LMLyle R. McKinnon
Lyle R. McKinnon
NYNonhlanhla Yende-Zuma
Nonhlanhla Yende-Zuma
NGNigel Garrett
Nigel Garrett
CBCheryl Baxter
Cheryl Baxter
QKQuarraisha Abdool Karim
Quarraisha Abdool Karim
Human papillomavirus (HPV) infection correlates with higher rates of HIV acquisition, but the underlying biological mechanisms are unclear. Here we study associations between HPV and HIV acquisition and relate these to vaginal cytokine profiles in an observational cohort of women at high risk of HIV infection (CAPRISA 004, n = 779) and with 74% HPV prevalence. We report here that HPV infection associates with a 2.5-fold increase in HIV acquisition risk in this population (95% CI: 1.2–5.3). Among 48 vaginal cytokines profiled, cytokines associated with HPV infection overlap substantially with cytokines associated with HIV risk, but are distinct from those observed in HPV negative women. Although our data do not establish a causative link between HPV status and the risk of HIV, we suggest that increasing HPV vaccination coverage may carry an additional benefit of reducing the risk of contracting HIV infection, particularly in regions with high HPV prevalence.